港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

高瓴概念

479.992

-5.710-1.18%

漲家數：17

跌家數：35

平家數：3

市盈率：- -

高：496.899

開：486.056

低：478.998

收：485.703

資料載入中...

【灣區早參】香港金管局調查：75%中小企指上季銀行貸款批核取態無分別或較容易

Bitwise已向美國SEC提交現貨NEAR ETF的上市申請

萬泰生物艾滋自檢試劑通過世衞組織PQ認證；歸創通橋5月9日起摘“B”丨醫藥早參

每日经济新闻

【雲頂新耀(01952.HK)：耐賦康®獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者】雲頂新耀(01952.HK)發佈公告，耐賦康®(NEFECON®)已獲中國國家藥品監督管理局的完全批准，取消了對蛋白尿水平的限制，用於治療具有疾病進展風險的原發性IgA腎病成人患者。此次完全批准意味着耐賦康®成為中國首個且唯一獲得中國藥監局完全批准的IgA腎病對因治療藥物。

雲頂新耀(01952)：耐賦康獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者

智通财经网

Bitwise 提交現貨 NEAR ETF 的 S-1 申請

建業新生活“迎舊人” 王俊時隔三年重回CEO

歸創通橋成為港股首家成功“摘B”的18A高值耗材醫療器械公司

灰度：Diana Zhang 將擔任首席運營官

灰度：Diana Zhang將擔任首席運營官

和鉑醫藥-B(02142)5月6日斥資345.8萬港元回購40萬股

歸創通橋(02190)成為港股首家成功“摘B”的18A高值耗材醫療器械公司

大消息！香港證監會、港交所宣佈

中国基金报

RWA 平台 Hadron by Tether 集成 Chainalysis 合規和監控工具

Tether 旗下資產代幣化平台 Hadron 已整合 Chainalysis 合規工具

21Shares 推出 Cronos ETP 並已在泛歐交易所巴黎和阿姆斯特丹平台交易

21Shares推出Cronos ETP並已在泛歐交易所巴黎和阿姆斯特丹平台交易

5月6日東方紅智華三年持有混合A淨值增長1.50%，今年來累計下跌0.21%

歸創通橋-B：中英文簡稱自5月9日起將不再加上標記“B”

京東健康攜手温醫大附一院探索“未來數字醫院”建設推動醫療大模型落地應用

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":479.99228,"timestamp":1746605303411,"preClose":485.70267,"halted":0,"volume":605138919,"delay":0,"changeRate":-0.011757,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":-5.710388,"latestTime":"05-07 16:00:00","open":486.0563,"high":496.89902,"low":478.99838,"amount":16814609850,"amplitude":0.036855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746667800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1746581400000,1746590400000],[1746594000000,1746604800000]],"pbRate":2.302601,"peRate":22.350632,"turnoverRate":0.00421,"increases":15,"decrements":34,"flats":5,"marketCap":2704253913472,"floatMarketCap":2128547225472},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":496.89902,"amplitude":0.036855,"preClose":485.70267,"low":478.99838,"pbRate":"2.302601","latestPrice":479.99228,"volume":605138919,"delay":0,"open":486.0563,"prevYearClose":446.93042,"prevWeekClose":480.455,"prevMonthClose":473.358,"prevQuarterClose":505.776,"fiveDayClose":464.073,"twentyDayClose":513.369,"sixtyDayClose":452.099,"secType":"PLATE","market":"HK","turnoverRate":0.00421,"peRate":22.350632,"marketCap":2704253913472,"floatMarketCap":2128547225472,"timestamp":1746605303411,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":17,"down":35,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533354690","title":"【灣區早參】香港金管局調查：75%中小企指上季銀行貸款批核取態無分別或較容易","url":"https://stock-news.laohu8.com/highlight/detail?id=2533354690","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533354690?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 08:29","pubTimestamp":1746577752,"startTime":"0","endTime":"0","summary":"25%认为银行的有关取态“较困难”，低于前一季的30%。3%受访者表示曾于第一季向银行申请新贷款。其中，5月2日的入住率最高，达98.1%。民航客运量累计达133.61万人次，同比增长24.51%。生效后，Vesync将向联交所申请撤销股份的上市地位。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958193","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03913","BK1154","BK1147","BK1240","BK1202","06098","BK1144","BK1214","03958","BK1558","159982","01128","BK1610","BK1258","BK1555","BK1172","BK1589","02148","399300","BK1583","BK1564","03931","BK1507","BK1557","BK1594","BK1554","BK1542","BK1229","01033","BK1521","02007","00182","BK1562"],"gpt_icon":0},{"id":"2533448694","title":"Bitwise已向美國SEC提交現貨NEAR ETF的上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2533448694","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533448694?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:43","pubTimestamp":1746574985,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cointelegraph.com/news/bitwise-files-s-1-near-etf-sec-approval-s1-filing","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK1583","BK4585","BK4539","BK4588","LU1861558580.USD","BK4112","COIN","BK4516","09983","BK4554","BK1258","BK4535","BK4595","BK1229","BK4550","BK4600","NEAR","BK4551","BK1542","LU1861559042.SGD","BK4596","FDN"],"gpt_icon":0},{"id":"2533692980","title":"萬泰生物艾滋自檢試劑通過世衞組織PQ認證；歸創通橋5月9日起摘“B”丨醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2533692980","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533692980?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:41","pubTimestamp":1746574879,"startTime":"0","endTime":"0","summary":"丨2025年5月7日星期三丨NO.1万泰生物：艾滋抗体尿液自检试剂通过世卫组织的PQ认证5月6日，万泰生物公告称，公司收到世界卫生组织（WHO）出具的体外诊断预认证（PQ）确认函，公司的HIV尿液自检试剂-人类免疫缺陷病毒1型尿液抗体检测试剂盒（胶体金法）已通过WHO的预认证，被WHO列入体外诊断产品预认证清单。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505073397377579.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505073397377579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","09633","BK1200","09939","BK1100","BK1589","BK1161","BK1587","02190","LU1981816686.USD","BK1583","BK1515"],"gpt_icon":0},{"id":"2533694521","title":"【雲頂新耀(01952.HK)：耐賦康®獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者】雲頂新耀(01952.HK)發佈公告，耐賦康®(NEFECON®)已獲中國國家藥品監督管理局的完全批准，取消了對蛋白尿水平的限制，用於治療具有疾病進展風險的原發性IgA腎病成人患者。此次完全批准意味着耐賦康®成為中國首個且唯一獲得中國藥監局完全批准的IgA腎病對因治療藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533694521","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533694521?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:15","pubTimestamp":1746573349,"startTime":"0","endTime":"0","summary":"云顶新耀(01952.HK)发布公告，耐赋康®(NEFECON®)已获中国国家药品监督管理局的完全批准，取消了对蛋白尿水平的限制，用于治疗具有疾病进展风险的原发性IgA肾病成人患者。此次完全批准意味着耐赋康®成为中国首个且唯一获得中国药监局完全批准的IgA肾病对因治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07071550177576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","01952","BK1574","BK1161"],"gpt_icon":0},{"id":"2533569450","title":"雲頂新耀(01952)：耐賦康獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2533569450","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533569450?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:12","pubTimestamp":1746573120,"startTime":"0","endTime":"0","summary":"云顶新耀发布公告，耐赋康已获中国国家药品监督管理局的完全批准，取消了对蛋白尿水平的限制，用于治疗具有疾病进展风险的原发性IgA肾病成人患者。此次完全批准意味着耐赋康成为中国首个且唯一获得中国药监局完全批准的IgA肾病对因治疗药物。这项研究为期2年，包括9个月的耐赋康或安慰剂治疗期，随后是15个月的停药随访期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-07/doc-inevssqn1568968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01952","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2533153699","title":"Bitwise 提交現貨 NEAR ETF 的 S-1 申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2533153699","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533153699?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 06:17","pubTimestamp":1746569843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7432848","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["BK1258","NEAR","09983","BK1229","BK1583","BK1542"],"gpt_icon":0},{"id":"2533669895","title":"建業新生活“迎舊人” 王俊時隔三年重回CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2533669895","media":"观点网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533669895?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 23:48","pubTimestamp":1746546480,"startTime":"0","endTime":"0","summary":"上一轮大换防中，王俊离开了建业新生活；三年后王俊重回旧地。自2018年6月加入建业集团开始，王俊便担任起建业新生活的董事。不过，建业新生活依旧受困于盈利水平下降难题。尽管建业新生活已实现扭亏为盈，营收重回增长，王俊此时接手的经营压力相对小于前两任CEO，但盈利水平提升并非易事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050702550094ee450b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050702550094ee450b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1542","BK1229","BK1258","09983","BK1583"],"gpt_icon":0},{"id":"2533658966","title":"歸創通橋成為港股首家成功“摘B”的18A高值耗材醫療器械公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2533658966","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533658966?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 22:21","pubTimestamp":1746541260,"startTime":"0","endTime":"0","summary":"5月6日，归创通桥医疗科技股份有限公司（归创通桥，2190.HK）宣布，公司已获得香港联交所批准，将于5月9日起正式将“B”标记从股份代码中移除，这也是港股首家成功“摘B”的18A高值耗材医疗器械公司。归创通桥称，“摘B”不仅标志着公司在市值和收入等方面达到了更高标准，是公司发展历程中的又一里程碑，也意味着公司持续增长及规模化盈利的能力获得资本市场认可，有利于进一步提升资本市场影响力。（澎湃新新闻记者 李潇潇）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506222205a6d523f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506222205a6d523f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","BK1574","HSCEI","02190","09996","BK1583","BK1587","BK1222","BK1100","09997"],"gpt_icon":0},{"id":"2533637318","title":"灰度：Diana Zhang 將擔任首席運營官","url":"https://stock-news.laohu8.com/highlight/detail?id=2533637318","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533637318?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 22:07","pubTimestamp":1746540455,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/Grayscale/status/1919754100360806908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["ETH","BK1258","BK4601","BK1229","09983","BK1583","BK1542"],"gpt_icon":0},{"id":"2533784632","title":"灰度：Diana Zhang將擔任首席運營官","url":"https://stock-news.laohu8.com/highlight/detail?id=2533784632","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533784632?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 22:02","pubTimestamp":1746540137,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 数字资产管理公司灰度在 X 平台发文宣布，Diana Zhang 将担任首席运营官。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/429626?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK1258","BK1229","BK4601","09983","BK1583","ETH","BK1542"],"gpt_icon":0},{"id":"2533632470","title":"和鉑醫藥-B(02142)5月6日斥資345.8萬港元回購40萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533632470","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533632470?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 21:59","pubTimestamp":1746539949,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，于2025年5月6日斥资345.8万港元回购40万股。于2025年5月2日-5月6日，根据首次公开发售后股份奖励计划而发行合计8万股普通股以满足股份奖励。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2533542634","title":"歸創通橋(02190)成為港股首家成功“摘B”的18A高值耗材醫療器械公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2533542634","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533542634?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 21:37","pubTimestamp":1746538624,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月6日，归创通桥医疗科技股份有限公司宣布，公司已获得香港联交所批准，将于5月9日起正式将“B”标记从股份代码中移除。归创通桥成为港股首家成功“摘B”的18A高值耗材医疗器械公司，不仅标志着公司在市值和收入等方面达到了更高标准，是公司发展历程中的又一里程碑;也意味着公司持续增长及规模化盈利的能力获得资本市场认可，有利于进一步提升资本市场影响力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02190","BK1222","09997","HSCEI","159883","BK1574","BK1100","BK1587","BK4614","HSTECH","BK1583","YANG","09996"],"gpt_icon":1},{"id":"2533639696","title":"大消息！香港證監會、港交所宣佈","url":"https://stock-news.laohu8.com/highlight/detail?id=2533639696","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533639696?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 20:50","pubTimestamp":1746535847,"startTime":"0","endTime":"0","summary":"【导读】5月6日，香港证监会与香港交易所正式推出“科企专线”5月6日，港股午后震荡上行。不过，恒生科技指数尾盘回落。截至收盘，恒指涨0.7%，报22662.71点；恒生国企指数指涨0.37%，报8261.61点；恒生科技指数跌0.09%，报5239.5点。全日大市成交额为2133.68亿港元，南向资金净买入额为134.75亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505063397035286.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505063397035286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0359201612.USD","HMTD.SI","LU0370786039.SGD","LU1303224171.USD","LU0594300419.USD","BK1583","LU0593848301.USD","LU0588545490.SGD","LU0128522157.USD","LU1328277881.USD","SG9999001689.USD","LU0345775950.USD","LU0577902371.SGD","LU0611395673.USD","LU1152091754.HKD","LU1102505929.USD","LU1808992512.USD","LU1770034418.SGD","LU0868486357.SGD","LU1102505762.USD","LU0417516571.SGD","LU1831875114.USD","LU1961090484.USD","LU2257852520.SGD","LU0348783233.USD","LU0541502299.USD","IE00BPRC5H50.USD","LU0269904917.USD","LU1734074674.USD","00027","LU0231483743.USD","LU1794554557.SGD","LU0320764599.SGD","LU0873338254.USD","LU1323998911.USD","LU0856984785.SGD","LU0348816934.USD","LU1242518931.SGD","LU0320764755.SGD","LU1224709979.USD","SG9999001903.USD","SG9999002828.SGD","LU2125910500.SGD","LU0607220059.USD","LU0384037296.USD","LU0039217434.USD","LU0918141887.USD","LU0819121731.USD"],"gpt_icon":1},{"id":"2533563531","title":"RWA 平台 Hadron by Tether 集成 Chainalysis 合規和監控工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2533563531","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533563531?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 20:26","pubTimestamp":1746534375,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7432146","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["BK1229","USDT.USD.CC","BK1583","BK1542","USDT.USD.HKCC","BK1258","09983"],"gpt_icon":0},{"id":"2533463862","title":"Tether 旗下資產代幣化平台 Hadron 已整合 Chainalysis 合規工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2533463862","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533463862?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 20:26","pubTimestamp":1746534364,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tether.io/news/hadron-by-tether-integrates-chainalysis-sets-new-standard-for-compliant-tokenization/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["USDT.USD.HKCC","BK1229","BK1542","BK1258","BK1583","USDT.USD.CC","09983"],"gpt_icon":0},{"id":"2533344635","title":"21Shares 推出 Cronos ETP 並已在泛歐交易所巴黎和阿姆斯特丹平台交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2533344635","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533344635?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 20:06","pubTimestamp":1746533194,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7432141","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["BK1258","BK1583","BK1229","BK4210","09983","BK1542","AG"],"gpt_icon":0},{"id":"2533680624","title":"21Shares推出Cronos ETP並已在泛歐交易所巴黎和阿姆斯特丹平台交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2533680624","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533680624?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 20:05","pubTimestamp":1746533138,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 加密资产管理公司 21Shares AG 宣布推出 Cronos ETP（交易所交易产品），为投资者提供对 Cronos 区块链原生代币 CRO 的受监管投资渠道，该产品目前在泛欧交易所巴黎和阿姆斯特丹平台上交易。（Financefeeds）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/429598?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["AG","BK1258","BK1229","BK1542","09983","BK4210","BK1583"],"gpt_icon":0},{"id":"2533687696","title":"5月6日東方紅智華三年持有混合A淨值增長1.50%，今年來累計下跌0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533687696","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533687696?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 19:54","pubTimestamp":1746532442,"startTime":"0","endTime":"0","summary":"金融界2025年5月6日消息，东方红智华三年持有混合A 最新净值0.7560元，增长1.50%。公开资料显示，东方红智华三年持有混合A基金成立于2021年8月18日，截至2025年3月31日，东方红智华三年持有混合A规模22.76亿元，基金经理为周云、刘中群。2025年02月15日担任东方红智华三年持有期混合型证券投资基金基金经理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/06195450171402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1229","BK1542","09983","BK1583","BK1258"],"gpt_icon":0},{"id":"2533682085","title":"歸創通橋-B：中英文簡稱自5月9日起將不再加上標記“B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2533682085","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533682085?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 19:47","pubTimestamp":1746532043,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥-B 发布公告，就根据香港联合交易所有限公司证券上市规则第18A.12条向香港联合交易所有限公司所作出的申请，联交所已授出批准上市规则第18A.09至第18A.11条不适用于公司的申请。由于相关规则不适用，公司的中英文简称自2025年5月9日起将不再加上标记“B”。公司的股份代号维持不变，仍为“2190”。公司为一间领先的介入医疗器械公司，根据上市规则第18A章，其普通股于2021年7月5日在联交所主板上市。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1574","BK1100","02190","BK1583"],"gpt_icon":0},{"id":"2533716684","title":"京東健康攜手温醫大附一院探索“未來數字醫院”建設 推動醫療大模型落地應用","url":"https://stock-news.laohu8.com/highlight/detail?id=2533716684","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533716684?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 19:39","pubTimestamp":1746531577,"startTime":"0","endTime":"0","summary":"本报讯（记者袁传玺）在日前由中国医院协会举办的“公立医院运营效能提升与创新发展”研讨会上，温州医科大学附属第一医院（以下简称“温医大附一院”）全面介绍了该院智慧医院建设的进展情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505063396971472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06618","BK1591","BK1583","BK1615","BK1142","86618","BK1515","BK1589","LU0456827905.SGD","BK1571","LU0051755006.USD","BK1247"],"gpt_icon":0}],"pageSize":20,"totalPage":41,"pageCount":5,"totalSize":813,"code":"91000000","status":"200"}]}}